| Thanks to SoCalBio Weekly Update Sponsor |
Coming in 2010 Benefiting Time: 10:00am - 8:30pm Where: Old Ranch Country Club, Seal Beach, California |
Take Advantage of SoCalBio's Group Purchasing Program to Cut the Cost of Doing Business |
Join SoCalBioJoin well-known entrepreneur Alfred Mann and other SoCalBio leaders to promote the biotech and device industries in the Greater Los Angeles Metro Area for job creation and overall economic growth. |  |
|
| February 22, 2010  |
|
Expansion
| Congratulations to Grifols Biologicals on Winning a City of Los Angeles High Growth Sector Labor Training Grant
Willie Zuniga, SoCalBio Board Member and Grifols' President & CEO, speaks about his company's plans to add 300 new jobs during a press conference on Feb. 18 which was attended by Los Angeles City Mayor Villaraigosa who announced WIB employee training grants to growth companies such as Grifols
|
 | |
| RSVP Now for Upcoming SoCalBio Events | 
SoCalBio Networking Forum Coming This Thursday
The Life-Science Industry in the Media
Join our star-studded panel of print and broadcast journalists for insights on how to use the media to promote your company and technology
RSVP Now: https://www.123signup.com/register?id=jyvbcPanelists- Mark Bernheimer, Founder and Principal Media Trainer, MediaWorks Resource Group
- Deborah Crowe, Journalist, Los Angeles Business Journal
- James Flanigan, Business Columnist, New York Times and other publications
- Frank Mottek, Anchor, Business Hour, KNX 1070
- Gerri Shaftel, Medical Producer, Fox 11 News
Moderator
- Erik Deutsch, Principal, ExcelPR Group
Date: February 25, 2010
Time: 4:00 pm - 7:00 pmLocation: Sierra Room, Wilshire Grand Hotel (downtown Los Angeles)
RSVP Now: https://www.123signup.com/register?id=jyvbc
************************************************
SoCalBio Executive Roundtable Discussion
Regenerative Medicine Luncheon and Discussion
(Open only to executives and managers in regenerative medicine companies)
Date: April 6, 2010
Time 11 - 2:00
Location: TBA
By Invitation Only (for more info, contact SoCalBio at scbc@socalbio.org or call 213-236-4890)
*************************************************
SoCalBio HR Symposium
Best Practices in Designing Wellness Programs
Join us to learn how to craft wellness programs to improve employee health, reduce medical claims, and guarantee a return on investment
(Open only to HR professionals in medical device, IVD, biotech and generic pharma firms)
Date: April 15, 2010
Time: 9:00am - 1:30pm
Location: One Lambda Corp. (Canoga Park)
By Invitation Only (for more info, contact SoCalBio at scbc@socalbio.org or call 213-236-4890)
Join the SoCalBio HR Network on LinkedIn
*************************************************
SoCalBio Regulatory Best Practice Workshop
The Shifting Paradigm in FDA Process Validation
This SoCalBio workshop focuses on the FDA's guidelines regarding Process Validation. It is designed for device and pharma regulatory affairs professionals to learn what is required to approach process validation from a life cycle perspective and incorporates modern risk management and quality systems tools and concepts. |
New SoCalBio Members
| 
An independent provider of clinical equipment maintenance and management solutions .. Learn more |
|  |
New Studies
| Healthcare Reform: Sustaining the Flow of Innovative Products
This is a study from SoCalBio member IMS Health. It contends that both comparative effectiveness research and changes to reimbursement and incentives have the potential to positively impact our nation's healthcare system, encourage the sort of innovation that is well-grounded in California, and accelerate the advancement of new approaches to diagnosis and treatment of a broad range of patient conditions. But they also can stop innovation in its tracks if they create an environment in which private capital is no longer attracted because the potential returns
are low or come with greater levels of risk....Read synopsis
Product Development: California's Biopharmaceutical Pipeline
This is another IMS Health study demonstrating that California remains the leader in drug development around the world. In fact, at the end of August 2009 there were some 869 products in the California biopharmaceutical pipeline, including those in pre-clinical and clinical development through registration. The pipeline includes products that California companies originated or invested in to address a broad range of diseases. The California biopharmaceutical pipeline represents about 15 percent of the total worldwide biopharmaceutical pipeline of 5,850 products....Read Synopsis |
FDA Drug Review
| FDA to Decide on Amgen's Osteoporosis Drug by July
The agency asked Amgen last October to provide additional information before it would proceed with its review and the company submitted its response in late January. The drug, also known as denosumab, is widely considered the most important growth driver in Amgen's development pipeline -- it is also being studied as a treatment for bone complications in cancer patients.... Read more |
New Initiatives
| Aubrey Group in Irvine Launches Entrepreneurial Services Program
The company-wide effort called the Entrepreneurial Services Program (ESP) that is focused on helping medical device entrepreneurs and inventors assemble the key ingredients required for a successful launch of product... Read more |
Personnel
| CNS Response Names Paul Buck Its Chief Financial Officer
 "Paul is a versatile, experienced finance executive who has done an outstanding job for us over the past year," said CNS Response CEO George Carpenter (photo right). "His proven leadership skills, strong track record and hands-on approach will further strengthen our management team. We look forward to benefiting from his expertise as we drive commercialization of our services in the healthcare industry" ... Read more |
| Jobs Available |  Agensys (Santa Monica)
Agensys is now part of Astellas Pharma
|
| About SoCalBio |  SoCalBio membership links you to partners, contract manufacturers, regulatory and legal experts, and policy makers. The organization's programs help emerging biotech and medical device companies grow. Membership is affordable -- as low as $500 -- and offers access to networking opportunities, advocacy, discounts through our group purchasing program group purchasing program and other benefits you simply can't find elsewhere ... Join SoCalBio |
|
|
